FDA’s Latest Nitrosamine Guidance Reinforces the need for a more Proactive Risk Management for Drug Developers and CDMOs
Alameda, California – August 3, 2026 – Emery Pharma today underscored the importance of the U.S. Food and Drug Administration’s…
PK vs PD on the MSD Platform: Similar Technology, Different Bioanalytical Strategies
The Meso Scale Discovery (MSD) platform has become a cornerstone technology for both large molecule pharmacokinetic (PK) assays and pharmacodynamic…
ADA Assay Development on MSD: Practical Execution and Critical Concepts
Introduction Anti-drug antibody (ADA) assays are critical for evaluating drug safety and are required throughout pre‑clinical and clinical development. In…
Case Study: Custom MSD Biomarker Development for 9 Analytes
Background Biomarker assessment is a critical component of pharmaceutical drug development, providing insight into how a therapeutic candidate affects biological…
When Pharma Meets the Courtroom: Why Neutral Third-Party Material Management Matters in Litigation
In pharmaceutical legal disputes – especially patent litigation, product liability cases, and regulatory investigations – the science isn’t the only…
Current State of Gene Therapy Development and Key Process & Analytical Challenges
Blog Emery Pharma | Dec 9, 2025 Introduction Gene therapy (GT) is an innovative approach designed to modify gene expression…
LBA Cross Validation: A Detailed Case Study
Validation vs Cross Validation Monoclonal antibody-based drugs have revolutionized the treatment of cancer and autoimmune diseases. Before a new antibody…
Protein Quantitation: Finding the Right Assay for Your Needs
The detection and quantitation of proteins, whether therapeutic agents or endogenous biomarkers, plays a central role in drug development and…
LCMS vs. GCMS: When to Choose Each for Optimal Results in Your Analytical Chemistry
In the world of analytical chemistry, selecting the right technique can be the key to unlocking precise and meaningful results.…
The Evolution of Gas Chromatography and later GC-MS and LC-MS. One Man’s Journey from Student to CEO
By: Dr. Ron NajafiCEO, Emery Pharma. The world of chromatography has undergone a remarkable transformation, evolving from basic ink separation…